Atlantic American Corp Dossier
|
SectorFinancials IndustryMulti-line Insurance Beta (adjusted)0.85 Intrinsic Value $2.84median of 2 methodsbased on filings through 30 Sep 2025 Market Price $1.31Price as of 30 Sep 2026 Significantly undervaluedIntrinsic value is 116% above the market price −50% · IV below pricenear fair value ±15%IV above price · +50% marker beyond scale (+116%) Data confidence Sign in to view data confidence Market Cap $26.7M Enterprise Value $30M Shares Outstanding 20.4M diluted Next Earnings Date12 Oct 2026 Last ex-dividend9 Apr 2025 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Atlantic American Corporation (AAME) is facing severe operational and regulatory headwinds. The company has failed to file its audited 2025 Form 10-K and Q1 2026 Form 10-Q on time, triggering Nasdaq non-compliance notices and prompting AM Best to place its core insurance subsidiaries under review with negative implications. Although the company reported positive trailing twelve-month earnings of $0.23 per share and a book value of $5.37 as of late 2025, the lack of current financial visibility and the risk of rating downgrades present significant downside risks that outweigh its low valuation multiples. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $1.1025% The company fails to meet the July 31, 2026 Truist Bank deadline and the October 12, 2026 Nasdaq deadline, leading to a technical default on its credit facility and potential delisting from the Nasdaq. AM Best downgrades the financial strength ratings of its subsidiaries, severely damaging its competitive position in specialty insurance markets. Base CaseCentral scenario $1.8050% The company files its delinquent reports by the extended Truist Bank deadline of July 31, 2026, or shortly thereafter, avoiding a credit default. However, the prolonged lack of transparency and the negative watch from AM Best weigh on investor sentiment, keeping the stock range-bound with limited liquidity. Bull CaseUpside scenario $2.5025% The company successfully resolves its accounting delays related to ASU 2018-12, files its delinquent reports before the October 12, 2026 Nasdaq deadline, and maintains its A- AM Best rating. Underwriting profitability continues to improve across both P&C and Life & Health segments, driving the stock price back toward its book value. Scenarios reflect our research view at the research date. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |